Biotech News: Mirror to Biotech Academia & Industry

Biotech news from India and across the globe. One stop site for your daily dose of Biotech industry , academia news and latest collaborations

While celebrities have a way of influencing our lives most of the times, there are a very few who take the task of educating the people for good.

Genomics England announced a new collaboration as part of the 100,000 Genomes Project, to accelerate the development of new diagnostics and treatments for patients.

President Obama’s administration today laid out a five-year, five-point plan for combating and preventing antibiotic-resistant bacteria—more than a month after proposing a near-doubling

Scientists believe that agricultural by-products, such as straw, sawdust and corncobs, can be used to create environment friendly biofuel to power cars.

GSK is encouraging academic scientists in Europe, Canada and the US to submit their novel early drug discovery research proposals into its third annual Discovery Fast Track Challenge – a prog

inStem and L’Oréa have announced research collaboration for the next three years to initiate research on different aspects of skin biology. The research agreement was signed by Prof.


The FDA issued an import alert last year for an IPCA Laboratories API plant in India after it discovered that employees had been falsifying drug testing results and deleting failed tests.

Cadila Healthcare, a Gujarat based drug maker which runs under the brand Zydus Cadila, has acquired entire 50 per cent stake in Zydus BSV Pharma Pvt Ltd (Zydus BSV) from its JV partner Bharat Serum

Six days ago, This company announced its Clinical Trial results for  Phase III , Expectations not just met reality, but caused a huge & "Never Seen Before" Press coverage, Invest

Who says there is no Funding, atleast not in US !! Flasgship Ventures has pooled 537 Million USD to support upcoming next gen BT Startups.

Avalanche Biotechnologies in Menlo Park and the University of Washington in Seattle announced a licensing agreement to develop the first treatment for colorblindness.

Sun Pharmaceutical Industries Ltd, India's largest drugmaker by sales, said on Wednesday its $3.2 billion acquisition of smaller rival Ranbaxy Laboratories LtdBSE -0.58 % will not restrict it f

Microbes may just be the next diet craze. Researchers have programmed bacteria to generate a molecule that, through normal metabolism, becomes a hunger-suppressing lipid.

Almost a year after announcing a $4 billion deal, Sun Pharmaceutical Industries said that merger of Ranbaxy with itself has been 'consummated' following receipt of requisite approvals.

Researchers in the Cockrell School of Engineering at The University of Texas at Austin have used a combination of metabolic engineering and directed evolution to develop a new, mutant yeast strain

Scientists have coaxed stem cells to grow the first three-dimensional mini lungs.

Calico, Google's health and antiaging startup, a company focused on aging research and therapeutics, and QB3, a University of California institute advancing biotechnology innovation, have partn

The Minister of State for Science & Technology and Earth Sciences, YS Chowdary, announced the launch of ‘BIRAC AcE Fund.’ The equity fund is aimed at addressing the pressing needs o

Dr Norman Warthmann, a plant geneticist at the ANU Research School of Biology, has lodged a submission with the UN, which is currently considering issues to include in its 2015 Global Sustainable D

In order to strengthen the surveillance of antimicrobial resistance (AMR) in the country, Indian Council of Medical Research (ICMR) has set up a Natio

The South Korean Ministry of Science, ICT and Future Planning, the Ministry of Trade, Industry and Energy, and other local agencies have announced plans to invest $300 million in fostering biotechn

The first attempt at extracting the nucleus of an intact dead cell of a mammoth, unearthed in Yakutia, with the aim of cloning the prehistoric animal has failed, the chief of the Sooam Biotech Rese

Scientists are to test a new two-shot Ebola vaccine using an experimental shot from Britain's GlaxoSmithKline, which is already in clinical trials in Africa, and a new kind of booster from Emer